BIO-TECHNE Corp — Director's Dealing 2023

Aug 17, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2023-08-15

Reporting Person: Bohnen Shane (SVP - General Counsel)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-08-15	Restricted Stock Units	$	A	4432	Acquired		Common Stock (4432)	Direct
2023-08-15	Stock Option (Right to Buy)	$84.61	A	11928	Acquired	2030-08-15	Common Stock (11928)	Direct
2023-08-15	Stock Option (Right to Buy)	$84.61	A	15904	Acquired	2030-08-15	Common Stock (15904)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Restricted Stock Units	$		Common Stock (6778)	6778	Direct
Stock Option (Right to Buy)	$73.76	2033-04-03	Common Stock (3928)	3928	Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.

F2: 2,259 shares vest on 4/3/24, 2,260 shares vest on 4/3/25 and 2,259 shares vest on 4/3/26.

F3: Options to purchase 982 shares vest on each of 4/3/24, 4/3/25, 4/3/26 and 4/3/27.

F4: Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

F5: Options to purchase 3,976 shares vest on each of 8/15/2024, 8/15/2025, 8/15/2026 and 8/15/2027.